e-ISSN: 2717-7149
  • Home
  • About The Journal
  • Editorial Board
  • Instructions for Authors
  • Contact
Current Issue
Ahead Of Print
Archive
Search
Most Popular
Download Articles Read Articles
Retina Arter Tıkanıklıkları ve Tedavisi...
Santral Retinal Ven Tıkanıklığı Güncel Tedavisi...
Central Retinal Artery Occlusion As the Cause of Unilateral Concentric Narrowing of Visual Field and Presence of Cilioretinal Artery...
Bilateral Optic Disc Drusen
Vascular Endothelial Growth Factor and Anti VEGF Agents...
Central Retinal Artery Occlusion As the Cause of Unilateral Concentric Narrowing of Visual Field and Presence of Cilioretinal Artery...
Retina Arter Tıkanıklıkları ve Tedavisi...
Morning Glory Syndrome Associated with Retinochoroidal Coloboma...
Santral Retinal Ven Tıkanıklığı Güncel Tedavisi...
Bilateral Optic Disc Drusen
PureSee Kesintisiz Yüksek Kalitede Görüş
Retina-Vitreous 2013 , Vol 21 , Num 3
Turkish Abstract Abstract Article PDF Similar Articles Mail to Author
The Effect of Intravitreal Bevacizumab Injection in Treatment of Diabetic Macular Edema
Erdinç CEYLAN1, Utku LİMON1, Barış YENİAD2, Koray AKARÇAY3, Nur KIR3, Tunç OVALI3
1M.D. Asistant, İstanbul University, İstanbul Medical Facuty, Department of Ophthalmology, İstanbul/TURKEY
2M.D., İstanbul University, İstanbul Medical Facuty, Department of Ophthalmology, İstanbul/TURKEY
3M.D. Professor, İstanbul University, İstanbul Medical Facuty, Department of Ophthalmology, İstanbul/TURKEY
Purpose: To evaluate visual acuity and foveal thickness alterations after intravitreal bevacizumab injection in treatment of diabetic macular edema.

Materials and Methods: 50 eyes of 43 patients with diabetic maculapathy that underwent single dose intravitreal bevacizumab (Avastin,) injection were analyzed retrospectively. Best corrected visual acuity (BCVA) was evaluated according Snellen chart . Foveal thickness was measured with optic coherence tomography (OCT) before and 1, 3 and 6 months after injection. Patients were compared in terms of BCVA and foveal thickness at 1st, 3th and 6th months.

Results: Mean follow-up period was 9.08±2.26 (6-15) months. Mean BCVA was determined as 0.29±0.19 before injection, 0.42±0.22 at 1st month, 0.37 ± 0.2 at 3th month and 0.33±0.18 at 6th month after injection. The improvement in visual acuity at 1st and 3th months were found statistically significant (p<0.01, p<0.01). The improvement in visual acuity at 6th month was not statistically significant (p=0.094). Mean foveal thickness was measured as 413.8±136 μm before injection, 309.9±103 μm, 330.8±123 μm and 369.3±156 μm at 1st, 3th and 6th months, respectively. The difference between preinjection and postinjection mean foveal thickness changes was founs statistically significant (p<0.01, p<0.01, p<0.02).

Conclusion: Effect of single dose intravitreal bevacizumab injection on visual acuity and foveal thickness in therapy of diabetic retinopathy with macular edema was reached the highest value in first month. The efficacy of injection are sustained for six months, although reduced. Keywords : Diabetic macular edema, intravitreal, bevacizumab

PureSee Kesintisiz Yüksek Kalitede Görüş
Home
About The Journal
Editorial Board
Instructions for Authors
Contact